Cyanotech Corporation (Nasdaq: CYAN) today announced the selection of Grant Thornton LLP ("Grant Thornton") as the Company's independent registered public accounting firm, subject to its customary client acceptance procedures.

Cyanotech Corporation (Nasdaq Capital Market: CYAN), a world leader in producing high-value nutrition and health products from microalgae, today announced that it will discontinue marketing of its NatuRose® product for the animal feed market in order to focus production and marketing of natural astaxanthin exclusively on the higher value human market.

Cyanotech Corporation (Nasdaq:CYAN), a world leader in producing high-value nutrition and health products from microalgae, announced new developments related to marketing of its industry-leading, natural astaxanthin product, BioAstin®.

Responding to questions related to news reports ab

Cyanotech Corporation (Nasdaq:CYAN) has obtained official regulatory approval (substantial equivalence) for its BioAstin® Natural Astaxanthin as a novel food in the European Union.